Top

BMC Urology

Published in:

Open Access 01-12-2005 | Research article

Microsatellite instability as prognostic marker in bladder tumors: a clinical significance

Authors: Minal Vaish, Anil Mandhani, RD Mittal, Balraj Mittal

Published in: BMC Urology | Issue 1/2005

Abstract

Background

Carcinoma of urinary bladder is one of the leading causes of death in India. Successful treatment of bladder cancer depends on the early detection & specific diagnostic approaches. In the present study, microsatellite instability (MSI) has been evaluated as a prognostic marker in patients with superficial urinary bladder cancer in lower urinary tract for determining risk of recurrence.

Methods

A total of 44 patients with bladder tumors diagnosed with Transitional Cell Carcinomas [TCC] from lower urinary tract were selected for the study. Tumors were staged and graded according to AJCC-UICC (1997) classification and patients were followed with cystoscopy as per the protocol. Polymerase chain reaction (PCR) was done to amplify microsatellite sequences at mononucleotide BAT – 26, BAT – 40, TGFβ RII, IGFIIR, hMSH3, BAX and dinucleotide D2S123, D9S283, D9S1851 and D18S58 loci in blood (control) and tumor DNA. PCR products were separated on 8% denaturing polyacrylamide gel and visualized by autoradiography.

Results

MSI was observed in 72.7% of tumors at BAT – 26, BAT – 40, D2S123, D9S283, D9S1851 and D18S58 loci. Good association of MSI was seen with tumor stage and grade. MSI – High (instability at > 30% of loci) was frequently observed in high stage (40.6%) and high grade (59.4%) tumors. Of 24 tumors of Ta-T1 stage with different grades, 11 (9/18 high grade and 2/6 low grade tumors) recurred in the mean duration of 36 months. MSI positivity was significantly high in patients who had one or more recurrences (p = 0.02 for high grade and 0.04 for low grade tumors).

Conclusions

MSI may be an independent prognostic marker for assessing risk of recurrence in superficial tumors irrespective of the grade. Further studies on progression would help in stratifying the patients of T1G3 for early cystectomy vs bladder preservation protocol.

Available only for authorised users

Takahashi T, Habuchi T, Kakehi Y, Mitsumori K, Akao T, Terachi T, Yoshida O: Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res. 1998, 58: 5835-5841.PubMed

von Knobloch R, Schullerus D, Reidmiller D, Kalble T: Allelic imbalance at chromosomes 5q, 8p and 17p as progression markers for bladder cancer. Aktuel Urol. 2000, 31: 83-86.

Ionov Y, Peinado MA, Malkhosyan S, Shibata D Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 1993, 363: 558-561. 10.1038/363558a0.CrossRefPubMed

Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D: Microsatellite alterations as clonal markers for the detection of human cancer. Proc Nat Acad Sci USA. 1994, 91: 9871-9875.CrossRefPubMedPubMedCentral

Leach FS: Molecular genetics of urothelial malignancies: Mismatch repair genes as markers for detection and prognosis?. Urologic Oncology. 2001, 6: 211-219. 10.1016/S1078-1439(01)00144-2.CrossRef

Sobin LH, Wittekind C: International Union Against Cancer (UICC). Urinary bladder. In TNM Classification of malignant tumors. 1997, NewYork: Wiley- Liss, 187-190.

Vaish M, Mishra SK, Mandhani A, Mittal RD, Mittal B: Assessment of microsatellite instability in bladder and thyroid malignancies. Teratog Carcinog Mutagen. 2003, 255-265. 10.1002/tcm.10053. Suppl 1

Zhou XP, Hoang JM, Cottu P, Thomas G, Hamelin R: Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene. 1997, 15: 1713-1718. 10.1038/sj.onc.1201337.CrossRefPubMed

Mukherjee M, Vaish Minal Mittal RD, Mittal B: Allelic variation of BAT-26 and BAT-40 poly-adenine repeat loci in North Indians. Int J Mol Med. 2002, 9: 91-94.PubMed

10.

Bonnal C, Ravery V, Toublanc M, Bertrand G, Boccon-Gibod L, Henin D, Grandchamp B: Absence of microsatellite in transitional cell carcinoma of the bladder. Urology. 2000, 55: 287-291. 10.1016/S0090-4295(99)00399-4.CrossRefPubMed

11.

Uchida T, Wang C, Wada C, Iwamura M, Egawa S, Koshiba K: Microsatellite instability and its relationship to clinicopathological variables and smoking. Int J Cancer. 1996, 69: 142-145.CrossRefPubMed

12.

Li M, Zhang ZF, Reuter VE, Cordon-Cardo C: Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol. 1996, 149: 229-235.PubMedPubMedCentral

13.

Amira N, Rivet J, Soliman H, Cancel-Tassin G, Le Duc A, Janin A, Cussenot O: Microsatellite instability in urothelial carcinoma of the upper urinary tract. J Urol. 2003, 170: 1151-1154. 10.1097/01.ju.0000086551.22844.cd.CrossRefPubMed

14.

Hartmann A, Cheville JC, Dietmaier W, Hofstadter F, Burgart LJ, Blaszyk H: Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. Arch Pathol Lab Med. 2003, 127: E60-63.PubMed

15.

Gonzalez-Zulueta M, Ruppert JM, Tokino K, Tsai YC, Spruck CH, Miyao N, Nichols PW, Hermann GG, Horn T, Steven K, Summerhayes IC, Sidransky D, Jones PA: Microsatellite instability in bladder cancer. Cancer Res. 1993, 53: 5620-5623.PubMed

16.

Christensen M, Jensen MA, Wolf H, Orntoft TF: Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer. Int J Cancer. 1998, 79: 396-401.CrossRefPubMed

17.

Danaee H, Nelson HH, Karagas MR, Schned AR, Ashok TD, Hirao T, Perry AE, Kelsey KT: Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. Oncogene. 2002, 21: 4894-4899. 10.1038/sj.onc.1205619.CrossRefPubMed

18.

Raghavan D: Molecular targeting and pharmacogenomics in the management of advanced bladder cancer. Cancer. 2003, 97: 2083-2089. 10.1002/cncr.11281.CrossRefPubMed

19.

Al-Sukhun S, Hussain M: Current understanding of the biology of advanced bladder cancer. Cancer. 2003, 97: 2064-2075. 10.1002/cncr.11289.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2490/5/2/prepub

Title: Microsatellite instability as prognostic marker in bladder tumors: a clinical significance
Authors: Minal Vaish
Anil Mandhani
RD Mittal
Balraj Mittal
Publication date: 01-12-2005
Publisher: BioMed Central
Published in: BMC Urology / Issue 1/2005
Electronic ISSN: 1471-2490
DOI: https://doi.org/10.1186/1471-2490-5-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Microsatellite instability as prognostic marker in bladder tumors: a clinical significance

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2005

BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking

Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina

Is DRE essential for the follow up of prostate cancer patients? A prospective audit of 194 patients

Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction

Vasectomy surgical techniques in South and South East Asia

Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder